Glaucoma practice varies across UK

Article

The practice of treating angle closure glaucoma (ACG) varies widely across the United Kingdom, according to a poster presented at the 8th congress of the European Glaucoma Society (EGS), held June 1–6 in Berlin.

The practice of treating angle closure glaucoma (ACG) varies widely across the United Kingdom, according to a poster presented at the 8th congress of the European Glaucoma Society (EGS), held June 1–6 in Berlin, Germany.

S. Dulku of Birmingham and Midland Eye Hospital, UK and colleagues conducted a national survey to assess current practice and compare peer-reviewed literature. Of the UK's 994 consultant ophthalmologists, 26% (n=258) sent eligible responses to the questionnaire, which was distributed in October 2007.

Of the eligible respondents, 31% (n=81) had an interest in glaucoma, 77% (n=66) of whom accepted tertiary referrals. All respondents assess the angle with gonioscopy, although there is no stage after this initial assessment at which respondents were in consensus regarding practice.

To grade the angle, 66% respondents use the Shaffer system. Exactly half of all respondents prescribe regular pilocarpine for the duration of prophylactic peripheral iridotomy (PI); 89% conduct bilateral PI in a single procedure. 58% use an agent to regulate intraocular pressure (IOP) during laser procedures; following surgical intervention, 55% monitor IOP the same day and 58% within two weeks. Uncontrolled IOP is most commonly treated with cataract surgery (68%) or clear lens extraction (58%), though 13% use goniosynechiolysis. Post-PI gonioscopy is performed by 61% of respondents.

In acute angle closure, 15% assess the eye with biometry. Of these, eyes with axial length <22 mm are assessed with the Hoffer Q formula (64%) and/or SRK-T (29%).  In these eyes, 84% of respondents noted increased complications, including iris prolapse (62%) and aqueous misdirection (29%).

The team concluded that, given the wide variations in practice made apparent by this study, the survey results could be used to formulate formal guidelines for the treatment of ACG.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
© 2025 MJH Life Sciences

All rights reserved.